ESGCT Rome

October 7, 2024

ESGCT Rome

ESGCT: European Society of Gene & Cell Therapy

22-25 october 2024 | Rome, Italy

Request a meeting with our team and visit us at booth #D37/D39

https://anemocyte.com/wp-content/uploads/2023/10/AMC_2023-ESG.jpg 1200 900 Anemocyte Anemocyte https://anemocyte.com/wp-content/uploads/2023/10/AMC_2023-ESG.jpg October 7, 2024 July 29, 2024

Anemocyte S.r.l. Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 21040 Gerenzano (VA) Italy | Ph: +39 02 99372311 – Fax: +39 02 99372313 | VAT number: 12914940155 | Share capital € 530.000,00 fully paid | R.E.A. 276961

Privacy & cookie Policy

ESGCT Rome

ESGCT Rome

ESGCT: European Society of Gene & Cell Therapy

22-25 october 2024 | Rome, Italy

Request a meeting with our team and visit us at booth #D37/D39

Anemocyte Pioneers Safer Horizons in Gene Therapy with Non-Viral Genetic Modification Techniques

The Perfect Recipe: Driving Sustainability, Flexibility, Quality, and Innovation in Cell and Gene Therapy

Our DNA: A Culture of Teamwork, Safety, and Strategic Growth